To assess the relevance of our previous findings to human leukaemia and to test whether different leukaemia subtypes show a different dependency of MYB expression as observed in the case of CEBPA mutations, we analysed publicly available array data [20] by classifying cases based on their karyotypic abnormalities. This evidence concerns the gene CEBPA and leukemia.